Schema-Root.org logo

 

  cross-referenced news and research resources about

 melanoma

Schema-Root.org logo
images:  google   yahoo YouTube
spacer

updated Wed. April 18, 2018

-
Mark Thomson is encouraging all Highlanders to take part in the Melanoma March on the 24th. Photo: Lauren Strode. Picton's Mark Thomson knows all too well that Wollondilly has one of the highest number of melamona cases. He was one of those cases. But he doesn't want anyone else to be a statistic.
The investigators sought to evaluate whether age is associated with clinical outcomes among patients with metastatic melanoma treated with immunotherapy. A total of 92 patients with metastatic melanoma who were treated between January 2007 and February 2016 with ipilimumab, nivolumab, ...

3. Li Y, Umbach DM, Li L. Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma. Melanoma Res. 2017;27:527-35. 4. Krauthammer M, Kong Y, Bacchiocchi A, et al. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
If you are a white New Zealander you are likely to get some form of skin cancer in your life time. That is according to Dr Richard Martin, one of the researchers attempting to assess the frequency of non-melenoma skin cancers in New Zealand. However, while melanoma cancers were recorded in the New ...
That's the prescription from La Jolla's DermTech, which offers skin tests for melanoma using a special adhesive tape. The genomic tests can quickly identify those who need further attention and reassure those who test negative for the cancer. One test, called DermTech PLA (Pigment Lesion Assay), ...
The bones in his back had been weakened by the disease, which had returned six months after he was given the all clear from his original melanoma ... Only 20 melanoma patients from around the world are on the trial and principle investigator Professor Georgina Long says so far, the results have been ...

Being treated with pembrolizumab has provided a longer life for patients with melanoma, says Whitman. Previously, patients with metastatic melanoma would be put on clinical trials, but the outcomes were not successful. However, now with the addition of pembrolizumab, patients seem to be doing quite ...
"My dad's younger sister was only 39 when she died of melanoma, that was 18 years ago. A month before my dad was diagnosed, his older sister was also diagnosed and she is still continuing with her treatment. My older brother has also had it on his cheek and currently gets three-monthly checks.".
"My dad's younger sister was only 39 when she died of melanoma, that was 18 years ago. A month before my dad was diagnosed, his older sister was also diagnosed and she is still continuing with her treatment. My older brother has also had it on his cheek and currently gets three-monthly checks.".
Three years on and as Mr Holland and his family are organising the first annual Melanoma March in Bendigo, to take place this Sunday. ... While recent Melanoma breakthroughs have tripled life expectancy for some advanced Melanoma patients, there is still much needed research that needs to be done in ...
TAKE A WALK: Veronica Manock is appealing to the community to support the Bathurst Melanoma March. Photo: CHRIS ... The event is part of the Melanoma Institute Australia's national fundraising effort for Melanoma research and this will be the sixth year Bathurst has held its own event. Coordinator ...
Money raised through the charity drives are donated to the Big Data for Melanoma Project, which focuses on creating a critical register to record the treatment and outcomes of patients with Melanoma, and to ensure everyone has the same standard of care to reduce deaths from this most dangerous form of ...
Melanoma is a type of cancer that develops from cells -- melanocytes -- that produce the pigment melanin. Melanin is responsible for protecting cells against the harmful effects of ultraviolet radiation. Melanocytes are most prevalent in the skin, but they are also present in other areas of the body. The most ...
The QIMR Berghofer Medical Research Institute developed the online test based on data from nearly 42,000 people aged from their forties to seventies. Professor David Whiteman from QIMR Berghofer said early detection of melanoma is vital, and the tool they've developed can help people identify if ...
A "highly accurate" online skin cancer test that can identify people at high risk of melanoma in 90 seconds has been developed by Queensland ... "Regular screening of those at higher risk may help detect melanomas early and hopefully before they have spread to the lower layers of the skin and other parts ...
Melanoma survivor Josh Drover with wife Michelle and daughter Mia (who was named after the Melanoma Institute of Australia. Picture: Robert Peet ... Kate Mitchell, Carmen Vescio, Glynnis Morris and Karen Ryan take part in the 2018 Melanoma March along North Wollongong, March 11. Picture: Robert ...
NEW YORK -- In this video commentary from HemOnc Today New York, co-program chair Sanjiv S. Agarwala, MD, summarizes highlights from the melanoma session. The session began with an overview of the basics of immunotherapy and side effect management. Subsequent presentations focused on ...

Austinmer local Jeff Dennis was diagnosed with melanoma in his shoulder back in 2000. ... "They used to say out of all the types of cancer melanoma was the one you want!" About 15 years ... The doctors found melanoma in his left lung and removed it, and once again Mr Dennis was given the all clear.
On average, melanoma patients who responded to the ILI procedure lived 56 months longer than non-responders. ILI has demonstrated response rates of between 54 and 84% for melanoma. Besides ILI, other treatments for soft tissue cancers including non-metastasized melanomas and sarcomas at Rush ...
Around the same time they were told the mole was melanoma, the young couple discovered they were expecting their third child. Fortunately the cancer was still contained -- capable of being cut out of his back, along with one lymph node. One month after baby Chloe was born, scans revealed the cancer ...
Individuals considered at high-risk of getting melanoma should get annual screenings. That's the feeling of a group of 50 dermatologists who authored a report in the journal melanoma Management. WSJ's Sumathi Reddy and Tanya Rivero discuss how the report follows a task force statement last year that ...
Caitlin is part of the 10 per cent of melanoma sufferers whose cancer spreads to the lymph nodes and isn't fixed with surgery alone. She had surgery on her neck to remove some of her lymph nodes, but three weeks later she found a lump in her neck near her surgical scar. "We went straight back to the ...
THURSDAY, Feb. 15, 2018 (HealthDay News) -- Obese men with advanced melanoma skin cancer seem to have a survival benefit over their slimmer peers, a new study suggests. Among men who received treatment for the potentially deadly cancer, obese patients lived an average of 47 percent longer than those with a ...
Researchers did a retrospective analysis of 1,918 people, 1,155 of them men, under treatment for metastatic melanoma. The study is in Lancet Oncology. Compared with men of normal weight, obese men in treatment had nearly double the progression-free survival time and nearly double the overall ...
In the frontline treatment of patients with advanced melanoma, the PD-1 inhibitor pembrolizumab (Keytruda) continues to be a promising immunotherapy option, according to a presentation by Eric Whitman, MD, at the 14th Annual International Symposium on melanoma and Other Cutaneous Malignancies.
"As an indication of clinical relevance, the abundance of mRNAs encoding Abl/Arg, Sp1, Ets1, and cathepsins was positively correlated in primary melanomas, and Abl/Arg-driven invasion in culture and metastasis in vivo required cathepsin secretion." The researchers also reported that ABL kinases ...
Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly. Both men were diagnosed with stage three metastatic Melanoma in their early 30s and told they had a 50/50 chance of surviving the following five ...
The combination of nivolumab plus ipilimumab was initially approved in October 2015 for the treatment for patients with BRAF V600 wild-type, unresectable or metastatic melanoma, which was based on findings from the phase II CheckMate-069 study. This indication was expanded in January 2016 to ...
cancer cells' ability to tolerate crowded conditions may be key to understanding how tumors form and grow, applying a mathematical model to cancer cell growth reveals. The model can replicate patterns of melanoma cell growth seen in laboratory experiments by controlling the "exclusion area"--the ...
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD Anderson cancer Center report in Lancet Oncology.
It seems likely that female melanoma patients often have better outcomes because estrogen increases the immune response against melanomas. But could men also benefit from these new findings? There is already evidence that some men may experience the benefits of estrogen on their melanomas.
And despite the fact that one in five Americans will develop skin cancer, some important risk factors and preventive measures are often overlooked. Alex Jokich explains what you can do to protect yourself in this week's Living Right. The most common sign of melanoma is a changing mole, but there are less ...
University of Queensland researchers have found that freckles and moles appearing on the iris indicate a high risk of melanoma, particularly in people under 40 years of age. Dermatology Research Centre's Associate Professor Rick Sturm said the presence of pigmented lesions was an effective predictor ...
Researchers in the Perelman school of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous pregnancy with better outcomes after a melanoma diagnosis. Now ...
Merck & Co. and Bristol-Myers Squibb have been head-to-head competitors in melanoma ever since their two immuno-oncology treatments, Keytruda and Opdivo, both won their first FDA approvals. Now, Keytruda has posted some new melanoma data that could help it play catch-up with Bristol-Myers' ...
A team of scientists from 10 different cancer centers around the globe - including Moffitt Cancer Center and UCLA - assessed 60 adults with advanced desmoplastic melanoma who received either Keytruda (pembrolizumab) or Opdivo (nivolumab). Forty-two patients (about 70 percent) had a significant ...
Unlike other cancers, melanoma can often be seen on the skin, making it easier to detect in its early stages. If left undetected, however, melanoma can spread to distant sites or distant organs. Once melanoma has spread to other parts of the body (known as stage IV), it is referred to as metastatic melanoma ...
According to the National cancer Institute, about 2.2% of people will be diagnosed with melanoma at a point in their lifetime.1 For those requiring surgery, the goal of adjuvant therapy is to increase relapse-free survival. Considering that patients with resected stage IV melanoma are often excluded from ...
"I went to a dermatologist, got it checked out, got it biopsied, and got a call back about two weeks later saying that it was melanoma," says Dahlman. Shocked by the diagnosis, the next step was surgery to remove the tumor. During this surgery they also do what's called a partial lymph-node dissection.
cancer is a group of 200 diseases responsible for the death of millions of lives every year. Cancer can be treated and cured with significant success rate if diagnosed at an early stage. Diagnosing cancer at advanced or later stages has proven to be very fatal. Hence, diagnosing cancer at an earlier stage is ...
The most common place to find melanomas is on the back for men and on the legs for women. However, in rare circumstances, melanoma can occur in the eye. Morgan and Reid also spoke to Joanne Morgan during the interview, a woman who had previously worked with Morgan while running the CNN ...
"The type of beta blocker we found to be effective against melanoma -- pan beta blockers -- was actually the least prescribed," Schell said. "Most patients are either prescribed beta 1 selective blockers or are not taking beta blockers at all. This means there's a large population of patients who may be ...
Maria Teresa Landi, MD, PhD, senior investigator, Integrative Tumor epidemiology Branch, National cancer Institute, discusses the importance of screening in melanoma. There is a balance between the necessity for screening and the overuse of health services, says Landi, but improving prevention is the ...
With the new finding, researchers Professor Sandra Loesgen and Terence Bradshaw have discovered the natural chemical mensacarcin, produced by the bacterium, is capable of attacking the mitochondria with a melanoma cell. The molecule is a secondary metabolite, and can be obtained in large ...
You likely know that melanoma is a dangerous form of skin cancer that's usually curable if you catch it early. So you know it's important to inspect your body regularly to watch for changes in moles or other lesions on your skin. But a recent Cleveland Clinic study concluded that it's also critical to get treatment ...
Immunotherapy is often the go-to therapy when melanoma -- the deadliest form of skin cancer -- has reached its most advanced stages, or when a person has recurrent forms of melanoma. Immunotherapy works by changing the patients' immune system and enabling it to better detect and attack malignant ...
Researchers at Penn State found that melanoma patients who received immunotherapy while taking a specific type of beta blocker lived longer than patients who received immunotherapy alone. In a follow-up experiment with mice, the researchers saw the same results. Dr. Todd Schell, professor of ...
"This result shows a significant advancement for patients that could potentially change the way melanoma is treated in the future," Alexander Eggermont, MD, PhD, study chair, director General at the Gustave Roussy cancer Institute, Professor of Oncology, University of Paris-Saclay, said in a statement.
There is an ongoing discussion in the field of metastatic melanoma regarding which treatment should be used first, immunotherapy or targeted therapy, as both are approved for the frontline treatment of these patients. Clinicians currently treating this disease have a variety of treatment options to choose ...
Since the approval of immune therapies for melanoma, concerns have been raised regarding the adequacy of standard RECIST criteria to identify responses and progression. "Patients who receive immunotherapy might develop an atypical response pattern, wherein they initially meet conventional ...


 

news and opinion


 


 


 


 


schema-root.org

   human
    diseases
     cancer
      skin
        melanoma